Summary
Updated Aug 31, 2026
Maria Cecilia Soriano is Group Pres., ITT & Pharma. of BAXTER INTERNATIONAL INC (BAX). 3 SEC Form 4 filings on record, most recently on 10 March 2026.
Recent Transactions
5Every recent SEC Form 4 transaction Maria Cecilia Soriano has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Maria Cecilia Soriano's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Paul B. Manning - $31.74M of LQDA open-market activity in the last 12 months
- LILLY ENDOWMENT INC - $3.10B of LLY open-market activity in the last 12 months
- KKR Phoenix Aggregator L.P. - $2.09B of BTSG open-market activity in the last 12 months
- KKR Group Partnership L.P. - $2.09B of BTSG open-market activity in the last 12 months
- WARBURG PINCUS CO. - $1.30B of SHC open-market activity in the last 12 months
- GTCR INVESTMENT XI LLC - $760.39M of SHC open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Maria Cecilia Soriano?
Maria Cecilia Soriano is a corporate insider, tracked as Group Pres., ITT & Pharma. of BAXTER INTERNATIONAL INC (BAX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Maria Cecilia Soriano last file a Form 4?
The most recent primary Form 4 on record is dated 10 March 2026, one of 3 filings going back to 2026.
Where can I see all of Maria Cecilia Soriano's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Maria Cecilia Soriano and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
